DGRO vs SCHD

DGROiShares Core Dividend Growth ETFvsSCHDSchwab US Dividend Equity ETF
Expense ratioNet assetsYield (TTM)Overlap1 yr5 yr*
DGRO0.08%$42.77B1.83%20%+21.8%+11.2%
SCHD0.06%$112.34B2.95%+38.9%+10.5%

Total returns with distributions reinvested; * a year. Prices as of Nov 2, 2026 · holdings and costs from SEC filings · page updated Nov 3, 2026

At a glance

20% of DGRO’s and SCHD’s holdings overlap by weight, with 32 securities in common out of 390 and 99. SCHD costs less: 0.06% a year against 0.08% for DGRO, or $60 against $80 on every $100,000. DGRO has $42.77B in assets and SCHD $112.34B; over the past 12 months DGRO paid out 1.83% of its price and SCHD 2.95%, both quarterly. Over the past year DGRO returned +21.8% and SCHD +38.9% with distributions reinvested; over five years, +11.2% and +10.5% a year. In the 2022 bear market DGRO fell 19.3% at its worst and SCHD 16.8%; both were back at their earlier highs 15 months after the low.

Key differences

DGROSCHD
FundiShares Core Dividend Growth ETFSchwab US Dividend Equity ETF
IssueriSharesSchwab
StructureOpen-end ETFOpen-end ETF
TypeDividend growthDividend
LaunchedJun 10, 2014Oct 20, 2011
Expense ratio0.08%0.06%
Cost a year on $100,000$80$60
Net assets$42.77B$112.34B
Holdings39099
Ten largest positions27.2%41.7%
Yield (12 months)1.83%2.95%
Paysquarterlyquarterly
Portfolio turnover25% a year30% a year
Price data fromJun 12, 2014Oct 20, 2011

Holdings and overlap

Overlap by weight20%the share of each fund in holdings both own
Securities in common32DGRO 390 · SCHD 99 in all
Ten largest positions27.2% / 41.7%of assets, DGRO / SCHD

Overlap adds up, for every security both funds own, the smaller of its two weights: 100% would mean identical portfolios.

Largest holdings

HoldingDGROSCHD
Merck & Co Inc1.91%4.76%
Amgen Inc1.30%4.70%
Abbott Laboratories1.10%4.68%
Coca-Cola Co1.96%4.16%
Chevron Corp—4.01%
Verizon Communications Inc—3.96%
ConocoPhillips0.89%3.93%
HOME DEPOT INC (THE)2.14%3.87%
PROCTER & GAMBLE COMPANY (THE)2.17%3.82%
UnitedHealth Group Inc1.76%3.82%
MICROSOFT CORP3.24%—
JP MORGAN CHASE & COMPANY3.16%—

The biggest differences in weight: Chevron Corp (0.0% in DGRO, 4.0% in SCHD); Verizon Communications Inc (0.0% in DGRO, 4.0% in SCHD); Abbott Laboratories (1.1% in DGRO, 4.7% in SCHD).

By sector

SectorDGROSCHDDifference
Health care16.0%21.3%SCHD +5.3
Financials18.1%5.2%DGRO +12.9
Consumer staples11.6%17.7%SCHD +6.1
Technology14.6%5.6%DGRO +9.0
Energy2.3%12.7%SCHD +10.4
Industrials8.5%9.0%SCHD +0.5
Consumer discretionary5.9%7.2%SCHD +1.3
Utilities5.4%0.0%DGRO +5.4
Communication services0.0%2.3%SCHD +2.3
Materials0.8%0.9%SCHD +0.1
Sectors of the companies each fund holds that have a stock page here (83.9% of DGRO, 81.7% of SCHD). Source: N-PORT holdings reports as of Jul 31, 2026 (DGRO) and Aug 31, 2026 (SCHD).

Returns

$0$25K$50K201520172019202120232025
DGRO SCHD · $10,000 in each on Jun 30, 2014, distributions reinvested.

$10,000 put into DGRO on Jun 30, 2014 was worth $43,176 on Nov 2, 2026, and in SCHD $42,042 (+12.6% and +12.3% a year). That is as far back as the price data for both goes.

1 yr3 yr5 yr10 yr
DGRO price data to Nov 2, 2026+21.8%+20.6%+11.2%+14.3%
DGRO official prospectus, to Dec 31, 2025+15.74%—+11.69%+13.10%
SCHD price data to Nov 2, 2026+38.9%+19.9%+10.5%+13.9%
SCHD official prospectus, to Dec 31, 2024+11.60%—+11.03%+11.03%
Multi-year figures are annualized total returns with distributions reinvested. "Official" rows are the SEC-standard returns from each fund's prospectus, to the end of the last calendar year; they reach back further where the price data starts late.

Calendar years

YearDGROSCHDDifference
2026+18.7% *+34.1% *SCHD +15.4
2025+15.7%+4.3%DGRO +11.4
2024+16.6%+11.6%DGRO +5.0
2023+10.5%+4.6%DGRO +5.9
2022-7.9%-3.2%SCHD +4.7
2021+26.6%+29.9%SCHD +3.2
2020+9.5%+15.1%SCHD +5.6
2019+29.9%+27.3%DGRO +2.6
2018-2.4%-5.5%DGRO +3.2
2017+23.0%+20.9%DGRO +2.1
Total returns from price data; * year to Nov 2, 2026.

Downturns and recovery

DGROSCHD
2008 financial crisis
stocks fell Oct 9, 2007 – Mar 9, 2009
Before it launchedBefore it launched
2020 COVID crash
stocks fell Feb 19, 2020 – Mar 23, 2020
−34.8% at the worst; back at its high 8 months after the low−32.8% at the worst; back at its high 5 months after the low
2022 bear market
stocks fell Jan 3, 2022 – Oct 12, 2022
−19.3% at the worst; back at its high 15 months after the low−16.8% at the worst; back at its high 15 months after the low
Worst fall in the price data−35.1% (Feb 12, 2020 – Mar 23, 2020)−33.4% (Jan 23, 2020 – Mar 23, 2020)
The deepest drop from a high to a low during each stretch when stocks fell, and how long the fund took to get back to its earlier high, with distributions reinvested. The price data starts Jun 12, 2014 for DGRO and Oct 20, 2011 for SCHD.

Income

DGRO yield (12 months)1.83%paid quarterly
SCHD yield (12 months)2.95%paid quarterly
YearDGROSCHD
2025$236$384
2024$256$389
2023$264$351
2022$209$317
2021$239$351
2020$245$349
2019$280$368
2018$233$283
Distributions paid during each calendar year on $10,000 of shares bought at the previous year-end close, adjusted for share splits. Before taxes.

Costs

SCHD charges 0.06% a year and DGRO 0.08%: on $100,000 that is $20 a year less with SCHD ($100 on $500,000). The fee comes out of each fund's assets, so it is already in the returns above.

Cost of $10,000 (SEC example)1 yr3 yrs5 yrs10 yrs
DGRO$8$26$45$103
SCHD$6$19$34$77
From each fund's prospectus: the total costs on $10,000 invested, at a 5% yearly return, with the shares sold at the end of each period.
Picked a fund? Check the plan around it. ReadyAimRetire shows whether your savings, Social Security and spending hold up year by year, whichever funds you hold.
Test my plan →

Sources

  • DGRO: 485BPOS prospectus (risk/return XBRL), filed Aug 21, 2026 — SEC EDGAR
  • DGRO: N-PORT holdings report, filed Sep 25, 2026 — SEC EDGAR
  • SCHD: 485BPOS prospectus (risk/return XBRL), filed Dec 22, 2025 — SEC EDGAR
  • SCHD: N-PORT holdings report, filed Oct 27, 2026 — SEC EDGAR
  • Prices: daily prices and distributions through Nov 2, 2026

For education only, not investment advice or a recommendation to buy or sell either fund. Past performance does not predict future results.